Thursday, March 27, 2025
Home Authors Posts by Editor / Curator

Editor / Curator

932 POSTS 0 COMMENTS
Video

NanoVibronix (NAOV) CEO Brian Murphy on Fox News.

Editor / Curator -
Internet News

Galaxy Next Generation (GAXY) Commitment of $600,000 From a Single...

Editor / Curator -
nanovibronix, biotech stock review
Research

NanoVibronix (NAOV) $3.35, Gets $10.50 Price target from Dawson James.

Editor / Curator -
Dr. Lindsay Rosenwald
Biotech News

Dr Lindsay Rosenwald, Biography.

Editor / Curator -
Internet Stock Review
Research

Model Portfolio

Editor / Curator -
biotech stock review
All News

Orchestra BioMed™ Announces Completion of $41 Million Financing.

Editor / Curator -
All News

Immunomedics Chairman Buys $19 Million More in Stock.

Editor / Curator -
Steven Boyd, Armistice
Biotech News

Steven Boyd, Armistice Capital Ranked #2 in Rising Hedge Fund Stars...

Editor / Curator -
eCommerce

Internet Stock Review Initiates Coverage On HealthLynked Corp. (HLYK) $0.23.

Editor / Curator -
AI Artificial Intelligence

Bradley Rotter: Cybersecurity: AI, Friend or Foe?

Editor / Curator -
1...909192...94Page 91 of 94

Latest article

Zomedica (ZOMDF) Surges 40% Higher, Friday.

Uncategorized Editor / Curator -
Stock Surges 40%, After Management Conference Call to Calm the Natives. Insider Buying Unleashed Today? Not...

And We Have a Trading Idea!

2025 Watch List Editor / Curator -
Adding Zomedica (ZOM, ZOMDF) $0.037 to Watch List. Our first 'publicly announced' trading idea, in what might be decades....

We’re Back! And We’re Adding (again), GeoVax (GOVX), the Alkaline Water Co (WTER) and...

2025 Watch List Editor / Curator -
GeoVax (GOVX) $1.64. Recent High $11.18 (BiotechStockReview) The Alkaline Water Co. (WTER) $0.09. Recent High $0.48 (BeverageStockReview)
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.